Update on the genetics of the idiopathic inflammatory myopathies

Current Opinion in Rheumatology

Volumn 12, Issue 6, 2000, Pages 482-491

  Shamim, Ejaz A ^a   Rider, Lisa G ^a   Miller, Frederick W ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; AUTOIMMUNE DISEASE; CAUCASIAN; CELL VACUOLE; CHROMOSOME 6; DERMATOMYOSITIS; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; ETHNOLOGY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; IDIOPATHIC INFLAMMATORY MYOPATHY; INCLUSION BODY MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROLOGY; SERUM GROUP GM SYSTEM;

AUTOIMMUNE DISEASES; HLA ANTIGENS; HUMANS; MYOSITIS; RISK FACTORS;

EID: 0033753570     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200011000-00002     Document Type: Review

References (87)

1. Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982
2. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies
3. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: A tale of two loci
4. Clinical serologic and genetic differences between US caucasian and meso-Americans with idiopathic inflammatory myopathy (IIM)
5. Association of HLA class I and class II alleles with myositis in Japanese patients
6. Familial autoimmunity and the idiopathic inflammatory myopathies
7. Genetic background and environment contribute synergistically to the onset of autoimmune diseases
8. Genetics of environmentally-associated rheumatic disease
9. Genetics of inclusion body myopathies
10. Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus
11. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy
12. Deficiency of the fas apoptosis pathway without fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer
13. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives
14. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases
15. Familial clustering of rheumatoid arthritis with other autoimmune diseases
16. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
17. Population choice in mapping genes for complex diseases
18. Cytokine gene polymorphism in human disease: On-line database
19. The IgG Fc receptor family
20. Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex
21. Juvenile rheumatoid arthritis as a complex genetic trait
22. Polymyositis acuta progressiva
23. Dermatomyositis: Report of 26 cases in children with a discussion of endocrine therapy in 13
24. Recurrent orbital myositis: Report of a familial incidence
25. Familial dermatomyositis
26. Acute familial myositis with a common autoimmune response
27. Familial inclusion body myositis: Evidence for autosomal dominant inheritance
28. Clinical and immunogenetic features of woman who develop myositis after silicone implants
29. New-onset juvenile dermatomyositis: Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis
30. Immunogenetic studies of juvenile dermatomyositis: HLA antigens in patients and their families
31. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: Increased risk associated with HLA-DQA1 *0501
32. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis
33. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups
34. Analysis of HLA-DM polymorphism in juvenile dermatomyositis (JDM) patients
35. Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis
36. Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain
37. Penicillamine-induced myositis: Observations and unique features in two patients and review of the literature
38. HLA-D region genes and susceptibility to D-penicillamine-induced myositis
39. Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations
40. TCR gene polymorphism and autoimmune diseases
41. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: A review
42. Interleukin-1 receptor antagonist: Role in biology
43. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases
44. Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies
45. Polymorphisms in cytokine genes are associated with juvenile idiopathic inflammatory myopathy (JIIM)
46. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
47. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha
48. Muscle biopsy finding in 38 untreated children with juvenile dermatomyositis (JDM): Capillary occlusion is associated with the TNF 2 allele
49. TNF alpha-308A allele in juvenile dermatomyositis: Associations with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications
50. HLA associations with inclusion body myositis
51. Prion protein is abnormally accumulated in inclusion-body myositis
52. Methionine homozygosity at prion gene codon 129 may predispose to sporadic inclusion-body myositis
53. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins
54. Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases
55. Apolipoprotein E epsilon 4 in inclusion body myositis
56. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease
57. The TNFA2 allele (AA, GA) is associated with calcinosis, a chronic disease course, and increased in vitro production of TNF-alpha but not TGF-beta by peripheral blood mononuclear cells (PBMCs) from children with juvenile dermatomyositis
58. Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research
59. The emerging importance of genetics in epidemiologic research. I. Basic concepts in human genetics and laboratory technology
60. The emerging importance of genetics in epidemiologic research II. Issues in study design and gene mapping
61. The emerging importance of genetics in epidemiologic research III. Bioinformatics and statistical genetic methods
62. Transmission disequilibrium test (TDT) when only one parent is available: The 1-TDT
63. Genetic epidemiology
64. Unusual clustering of diseases in a Canadian Old Colony (Chortitza) Mennonite kindred and community
65. Rheumatoid arthritis: Nature or nurture?
66. Concordance rates of insulin dependent diabetes mellitus: A population-based study of young Danish twins
67. Twin concordance rates for rheumatoid arthritis: Results from a nationwide study
68. The genetics of multiple sclerosis: A review
69. From genome to aetiology in a multifactorial disease, type 1 diabetes
70. Systemic lupus erythematosus candidate genes in the Italian population: Evidence for a significant association with interleukin-10
71. Genetic susceptibility to the connective tissue diseases
72. Uber die Dermatomyositis
73. Familial occurrence of dermatomyositis case reports and a family survey
74. Juvenile dermatomyositis in first cousins
75. Childhood dermatomyositis in monozygotic twins
76. Familial inclusion body myositis among Kurdish-Iranian Jews
77. C4 null genes in American whites and blacks with myositis
78. HLA-D related (DR) antigens in various kinds of myositis
79. HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies
80. Immunogenetic studies in families of children with juvenile dermatomyositis
81. Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies
82. C4 Complement allotypes in juvenile dermatomyositis
83. The Jo-1 antibody system in myositis: Relationships to clinical features and HLA
84. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl
85. Serum autoantibody to the nucleolar antigen PM-Scl: Clinical and immunogenetic associations
86. Antibodies against Ku protein in sera from patients with autoimmune diseases
87. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain: Recent approaches to diagnosis and pathogenesis, and relation to aging